Syngene International Ltd (SYNGENE) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Thyrocare Tech.

Indegene

Dr Lal Pathlabs

Metropolis Healt

Vijaya Diagnost.

Vimta Labs

Nephrocare Healt

Krsnaa Diagnost.

Suven Life Scie.

Poly Medicure

Syngene Intl.

Why is Syngene International Ltd ?

Poor long term growth as Operating profit has grown by an annual rate -4.05% of over the last 5 years

With a fall in Net Sales of -28.99%, the company declared Very Negative results in Jun 26

PAT(Q) At Rs 4.50 cr has Fallen at -95.0% (vs previous 4Q average)
ROCE(HY) Lowest at 10.12%
OPERATING PROFIT TO INTEREST (Q) Lowest at 9.46 times

With ROE of 7.4, it has a Very Expensive valuation with a 3.4 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -40.07%, its profits have fallen by -45.5%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -40.07% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Syngene Intl. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Syngene Intl.

-40.07%

-1.24

32.43%

Sensex

-2.63%

-0.19

13.57%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

8.84%

EBIT Growth (5y)

-4.05%

EBIT to Interest (avg)

12.48

Debt to EBITDA (avg)

0.82

Net Debt to Equity (avg)

-0.17

Sales to Capital Employed (avg)

0.69

Tax Ratio

23.90%

Dividend Payout Ratio

10.14%

Pledged Shares

Institutional Holding

39.83%

ROCE (avg)

15.48%

ROE (avg)

11.03%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.37

EV to EBIT

44.28

EV to EBITDA

19.25

EV to Capital Employed

3.86

EV to Sales

4.29

PEG Ratio

Dividend Yield

0.30%

ROCE (Latest)

11.62%

ROE (Latest)

7.41%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

DEBT-EQUITY RATIO(HY)

Lowest at 0.10 times

-25What is not working for the Company

NET SALES(Q)

At Rs 736.00 cr has Fallen at -21.3% (vs previous 4Q average

PBT LESS OI(Q)

At Rs -31.00 cr has Fallen at -129.8% (vs previous 4Q average

PAT(Q)

At Rs 4.50 cr has Fallen at -95.0% (vs previous 4Q average

ROCE(HY)

Lowest at 10.12%

OPERATING PROFIT TO INTEREST (Q)

Lowest at 9.46 times

PBDIT(Q)

Lowest at Rs 90.80 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at 12.34%

EPS(Q)

Lowest at Rs -0.22

Loading Valuation Snapshot...

Here's what is working for Syngene Intl.

Debt-Equity Ratio - Half Yearly

Lowest at 0.10 times

in the last five half yearly periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Syngene Intl.

Net Sales - Quarterly

At Rs 736.00 cr has Fallen at -21.3% (vs previous 4Q average)

over average Net Sales of the previous four quarters of Rs 934.68 Cr

MOJO Watch

Near term sales trend is very negative

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs -31.00 cr has Fallen at -129.8% (vs previous 4Q average)

over average PBT of the previous four quarters of Rs 104.20 Cr

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 4.50 cr has Fallen at -95.0% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs 89.63 Cr

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)

Operating Profit to Interest - Quarterly

Lowest at 9.46 times

in the last five quarters

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Net Sales - Quarterly

Lowest at Rs 736.00 cr

in the last five quarters

MOJO Watch

Near term sales trend is negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly

Lowest at Rs 90.80 cr.

in the last five quarters

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly

Lowest at 12.34%

in the last five quarters

MOJO Watch

Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly

Lowest at Rs -31.00 cr.

in the last five quarters

MOJO Watch

Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly

Lowest at Rs -0.22

in the last five quarters

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Non Operating Income - Quarterly

Highest at Rs 25.30 cr

in the last five quarters

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating Income